{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:49:12Z","timestamp":1767134952239,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd007324.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T00:00:00Z","timestamp":1441756800000}}],"reference-count":86,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007324.pub3","type":"journal-article","created":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T22:17:24Z","timestamp":1441837044000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion"],"prefix":"10.1002","volume":"2021","author":[{"given":"Dina","family":"Gewaily","sequence":"additional","affiliation":[{"name":"Deglin and Greene Retinal Center; Wynnewood Pennsylvania USA"},{"name":"Department of Ophthalmology; Scheie Eye Institute, University of Pennsylvania; Philadelphia Pennsylvania USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthikeyan","family":"Muthuswamy","sequence":"additional","affiliation":[{"name":"Cooper University Hospital; Camden New Jersey USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology; Warren Alpert Medical School of Brown University; Providence Rhode Island USA"},{"name":"Section of Ophthalmology; VA Medical Center; Providence Rhode Island USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,9,9]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD007324.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","article-title":"Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results","volume":"118","author":"Haller","year":"2011","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD007324.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD007324.pub3-BIB0003|cit3","unstructured":"Haller JA Blumenkranz MS Williams GA Kuppermann BD Treatment of persistent macular edema associated with central and branch retinal vein occlusion with extended delivery of intravitreal dexamethasone Investigative Ophthalmology and Visual Science 2003 44 2 ARVO E abstract 4311"},{"issue":"9","key":"10.1002\/14651858.CD007324.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/IAE.0000000000000167","article-title":"Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion","volume":"34","author":"Kuppermann","year":"2014","journal-title":"Retina"},{"issue":"6","key":"10.1002\/14651858.CD007324.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ophtha.2011.12.028","article-title":"Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant","volume":"119","author":"Yeh","year":"2012","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD007324.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archophthalmol.2010.193","article-title":"Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE study report 9","volume":"128","author":"Blodi","year":"2010","journal-title":"Archives of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD007324.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archophthalmol.2009.277","article-title":"The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4","volume":"127","author":"Domalpally","year":"2009","journal-title":"Archives of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD007324.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.ophtha.2009.03.022","article-title":"SCORE study report 3: study design and baseline characteristics","volume":"116","author":"Ip","year":"2009","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD007324.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5","volume":"127","author":"Ip","year":"2009","journal-title":"Archives of Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD007324.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1001\/archophthalmol.2009.347","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Erratum","volume":"127","author":"Ip","year":"2009","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD007324.pub3-BIB0011|cit11","unstructured":"Myers D Blodi B Ip M Scott I Warren K Reading center evaluation of OCT images from patients enrolled in the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study Investigative Ophthalmology and Visual Science 2006 47 ARVO E abstract 5194"},{"issue":"5","key":"10.1002\/14651858.CD007324.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajo.2009.06.004","article-title":"SCORE study report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design","volume":"148","author":"Scott","year":"2009","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007324.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ophtha.2010.06.034","article-title":"Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10","volume":"118","author":"Scott","year":"2011","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007324.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ophtha.2008.10.017","article-title":"SCORE study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion","volume":"116","author":"Scott","year":"2009","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007324.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/IAE.0b013e318263d106","article-title":"SCORE study report 12: development of venous collaterals in the SCORE study","volume":"33","author":"Weinberg","year":"2013","journal-title":"Retina"},{"issue":"8","key":"10.1002\/14651858.CD007324.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archopht.122.8.1137","article-title":"Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion","volume":"122","author":"Bashshur","year":"2004","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007324.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12009-007-9016-x","article-title":"Two-year results of intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion","volume":"39","author":"Batioglu","year":"2007","journal-title":"Annals of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007324.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/eye.2008.136","article-title":"Intravitreal triamcinolone acetonide for patients with macular oedema due to central retinal vein occlusion in Taiwan","volume":"23","author":"Cheng","year":"2009","journal-title":"Eye"},{"issue":"4","key":"10.1002\/14651858.CD007324.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/jop.2010.0039","article-title":"Secondary ocular hypertension after intravitreal injection with 2 mg or 4 mg of triamcinolone in retinal vein occlusion","volume":"26","author":"Chuang","year":"2010","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD007324.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0420.2005.00605.x","article-title":"Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone","volume":"84","author":"Gelston","year":"2006","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD007324.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF03163806","article-title":"Therapy of macular edema with an intravitreal dexamethasone implant","volume":"20","author":"Georgopoulos","year":"2006","journal-title":"Spektrum Der Augenheilkunde"},{"issue":"1","key":"10.1002\/14651858.CD007324.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ophtha.2011.06.019","article-title":"Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results","volume":"119","author":"Jain","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD007324.pub3-BIB0023|cit23","first-page":"639","article-title":"Clinical observation of intravitreal injection of triamcinolone acetonide for macular edema secondary to retinal vein occlusion","volume":"24","author":"Jiang","year":"2006","journal-title":"Chinese Ophthalmic Research"},{"issue":"6","key":"10.1002\/14651858.CD007324.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/112067210501500615","article-title":"Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion","volume":"15","author":"Jonas","year":"2005","journal-title":"European Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007324.pub3-BIB0025|cit25","first-page":"230","article-title":"Intravitreal triamcinolone acetonide for macular edema in retinal vein occlusion","volume":"8","author":"Manaviat","year":"2008","journal-title":"International Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007324.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/IEB.0b013e3181c7c878","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care versus Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5: comment","volume":"11","author":"Muni","year":"2010","journal-title":"Evidence-Based Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD007324.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00417-006-0348-9","article-title":"Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial","volume":"244","author":"Ramezani","year":"2006","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007324.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00417-012-2134-1","article-title":"A prospective, randomised, multicenter trial for surgical treatment of central retinal vein occlusion: results of the Radial Optic Neurotomy for Central Vein Occlusion (ROVO) study group","volume":"251","author":"Aggermann","year":"2013","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD007324.pub3-BIB0029|cit29","unstructured":"Safety and efficacy study of dexamethasone in the treatment of patients with macular edema following retinal vein occlusion (RVO) clinicaltrials.gov\/ct2\/show\/NCT01660802"},{"issue":"2","key":"10.1002\/14651858.CD007324.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000090579","article-title":"Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection","volume":"220","author":"Aggermann","year":"2006","journal-title":"Ophthalmologica"},{"issue":"11","key":"10.1002\/14651858.CD007324.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/bjo.2007.114843","article-title":"Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female","volume":"91","author":"Al-Dhibi","year":"2007","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007324.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitic cystoid macular oedema: an optical coherence tomography study","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD007324.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/jop.2011.0184","article-title":"Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion","volume":"28","author":"Bakri","year":"2012","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD007324.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/archopht.121.2.271","article-title":"Endophthalmitis caused by mycobacterium chelonae abscessus after intravitreal injection of triamcinolone","volume":"121","author":"Benz","year":"2003","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD007324.pub3-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007325.pub3","article-title":"Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion","author":"Braithwaite","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007324.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/jop.2012.0130","article-title":"Vitreous traction after Ozurdex injection","volume":"29","author":"Clemens","year":"2013","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD007324.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0886-3350(02)01441-4","article-title":"Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular oedema","volume":"29","author":"Conway","year":"2003","journal-title":"Journal of Cataract and Refractive Surgery"},{"issue":"3","key":"10.1002\/14651858.CD007324.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2012.09.026","article-title":"Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study","volume":"155","author":"Brown","year":"2013","journal-title":"American Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD007324.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.ophtha.2012.05.017","article-title":"Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials","volume":"119","author":"Varma","year":"2012","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD007324.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(95)30849-4","article-title":"Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion","volume":"102","author":"The Central Vein Occlusion Study Group","year":"1995","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007324.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","article-title":"Natural history and clinical management of central retinal vein occlusion","volume":"115","author":"The Central Vein Occlusion Study Group","year":"1997","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD007324.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archopht.1996.01100130537006","article-title":"Risk factors for central retinal vein occlusion","volume":"114","author":"The Eye Disease Case-Control Study Group","year":"1996","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007324.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ophtha.2013.08.012","article-title":"Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO study","volume":"121","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007324.pub3-BIB0044|cit44","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"8","key":"10.1002\/14651858.CD007324.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/01.iae.0000231543.45699.e1","article-title":"Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion","volume":"26","author":"Goff","year":"2006","journal-title":"Retina"},{"key":"10.1002\/14651858.CD007324.pub3-BIB0046|cit46","first-page":"371","article-title":"Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases","volume":"79","author":"Green","year":"1981","journal-title":"Transactions of the American Ophthalmological Society"},{"issue":"8","key":"10.1002\/14651858.CD007324.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/01.iae.0000237111.82357.30","article-title":"One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion","volume":"26","author":"Gregori","year":"2006","journal-title":"Retina"},{"key":"10.1002\/14651858.CD007324.pub3-BIB0048|cit48","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007324.pub3-BIB0049|cit49","doi-asserted-by":"crossref","unstructured":"Hirasawa M Noda K Shinoda H Ozawa Y Tsubota K Ishida S Secondary macular hole associated with central retinal vein occlusion treated with corticosteroid injection Japanese Journal of Ophthalmology 2009 53 3 279 81","DOI":"10.1007\/s10384-009-0665-8"},{"issue":"9","key":"10.1002\/14651858.CD007324.pub3-BIB0050|cit50","first-page":"1217","article-title":"Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion","volume":"120","author":"Ip","year":"2002","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007324.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1076\/soph.18.2.67.15860","article-title":"Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study","volume":"18","author":"Ip","year":"2003","journal-title":"Seminars in Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD007324.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archopht.122.8.1131","article-title":"Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion","volume":"122","author":"Ip","year":"2004","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007324.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1385\/AO:38:1:67","article-title":"Triamcinolone pseudo-cataract","volume":"38","author":"Jain","year":"2006","journal-title":"Annals of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD007324.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00417-002-0529-0","article-title":"Intravitreal triamcinolone acetonide as treatment of macular oedema in central retinal vein occlusion","volume":"240","author":"Jonas","year":"2002","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD007324.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1600-0420.2005.00592.x","article-title":"Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases","volume":"83","author":"Jonas","year":"2005","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"8","key":"10.1002\/14651858.CD007324.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/bjophthalmol-2013-303207","article-title":"Dexamethasone implants in retinal vein occlusion:12-month clinical effectiveness using repeat injections as-needed","volume":"97","author":"Joshi","year":"2013","journal-title":"British Journal of Ophthalmology Online"},{"issue":"2","key":"10.1002\/14651858.CD007324.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00006982-200404000-00030","article-title":"Intravitreal triamcinolone acetonide for the treatment of central retinal vein occlusion in young patients","volume":"24","author":"Karacorlu","year":"2004","journal-title":"Retina"},{"issue":"4","key":"10.1002\/14651858.CD007324.pub3-BIB0058|cit58","first-page":"758","article-title":"Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion","volume":"137","author":"Kaushik","year":"2004","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD007324.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3928\/1542-8877-20001101-07","article-title":"Retinal toxicity of triamcinolone acetonide in silicone-filled eyes","volume":"31","author":"Kivilcim","year":"2000","journal-title":"Ophthalmic Surgery and Lasers"},{"issue":"3","key":"10.1002\/14651858.CD007324.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.eye.6702416","article-title":"Ocular morbidity associated with intravitreal triamcinolone acetonide","volume":"21","author":"Konstantopoulos","year":"2007","journal-title":"Eye"},{"issue":"1","key":"10.1002\/14651858.CD007324.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0420.2005.00400.x","article-title":"Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion","volume":"83","author":"Krepler","year":"2005","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD007324.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/IAE.0b013e318030c517","article-title":"Retinal toxicity of intravitreal Kenalog in albino rabbits","volume":"27","author":"Lang","year":"2007","journal-title":"Retina"},{"issue":"3","key":"10.1002\/14651858.CD007324.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/112067210701700333","article-title":"Macular hole and intravitreal injection of triamcinolone acetonide for macular edema due to central retinal vein occlusion","volume":"17","author":"Lattanzio","year":"2007","journal-title":"European Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007324.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3129\/can.j.ophthalmol.06-091","article-title":"Surgical macular decompression for macular edema in retinal vein occlusion","volume":"42","author":"Mandelcorn","year":"2007","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007324.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ophtha.2006.11.011","article-title":"Interventions for central retinal vein occlusion: an evidence-based systematic review","volume":"114","author":"Mohamed","year":"2007","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD007324.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-006-9032-y","article-title":"Intraocular triamcinolone acetonide for macular edema due to CRVO. A multifocal-ERG and OCT study","volume":"114","author":"Moschos","year":"2007","journal-title":"Documenta Ophthalmologica"},{"issue":"3","key":"10.1002\/14651858.CD007324.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/09273940902745411","article-title":"Ocular syphilis unmasked following intravitreal triamcinolone injection","volume":"17","author":"Mushtaq","year":"2009","journal-title":"Ocular Immunology and Inflammation"},{"issue":"4","key":"10.1002\/14651858.CD007324.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1165\/ajrcmb.16.4.9115750","article-title":"Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids","volume":"16","author":"Nauck","year":"1997","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"2-3","key":"10.1002\/14651858.CD007324.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-2999(97)01464-7","article-title":"Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells","volume":"341","author":"Nauck","year":"1998","journal-title":"European Journal of Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD007324.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0181-5512(06)73851-7","article-title":"Surgical treatment of persistent macular edema in retinal vein occlusion","volume":"29","author":"Nkeme","year":"2006","journal-title":"Journal Francais d Opthalmologie"},{"issue":"1-2","key":"10.1002\/14651858.CD007324.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10792-006-0005-7","article-title":"Effects of intravitreal triamcinolone injection on macular edema and visual prognosis in central retinal vein occlusion","volume":"26","author":"Ozdek","year":"2005","journal-title":"International Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD007324.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/00006982-200512000-00022","article-title":"Decreased venous tortuosity associated with resolution of macular edema after intravitreal injection of triamcinolone","volume":"25","author":"Paques","year":"2005","journal-title":"Retina"},{"key":"10.1002\/14651858.CD007324.pub3-BIB0073|cit73","doi-asserted-by":"crossref","unstructured":"Pardo-Lopez D Frances-Munoz E Gallego-Pinazo R Diaz-Llopis M Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex(R)) Graefe's Archive for Clinical and Experimental Ophthalmology 2012 250 11 1703 4","DOI":"10.1007\/s00417-011-1802-x"},{"issue":"3","key":"10.1002\/14651858.CD007324.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","article-title":"Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion","volume":"136","author":"Park","year":"2003","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007324.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0161-6420(98)93020-2","article-title":"Vascular endothelial growth factor upregulation in human central retinal vein occlusion","volume":"105","author":"Pe'er","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD007324.pub3-BIB0076|cit76","unstructured":"The Nordic Cochrane Centre. The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"1","key":"10.1002\/14651858.CD007324.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/IAE.0b013e3181593e38","article-title":"Short-term complications of intravitreal injection of triamcinolone acetonide","volume":"28","author":"Roth","year":"2008","journal-title":"Retina"},{"issue":"2","key":"10.1002\/14651858.CD007324.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.exer.2006.10.006","article-title":"Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit","volume":"84","author":"Ruiz-Moreno","year":"2007","journal-title":"Experimental Eye Research"},{"key":"10.1002\/14651858.CD007324.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s10384-008-0576-0","article-title":"Cytomegalovirus retinitis after intravitreal triamcinolone acetonide in an immunocompetent patient","volume":"52","author":"Sekiryu","year":"2008","journal-title":"Japanese Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD007324.pub3-BIB0080|cit80","unstructured":"Shyangdan D Cummins E Lois N Royle P Waugh N Dexamethasone implants in the treatment of macular oedema due to retinal vein occlusion: a single technology appraisal www.nice.org.uk\/guidance\/ta229\/resources\/guidance-dexamethasone-intravitreal-implant-for-the-treatment-of-macular-oedema-secondary-to-retinal-vein-occlusion-pdf"},{"issue":"8","key":"10.1002\/14651858.CD007324.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.ico.0000159754.05736.8c","article-title":"Conjunctival necrosis following intravitreal injection of triamcinolone acetonide","volume":"24","author":"Srinivasan","year":"2005","journal-title":"Cornea"},{"issue":"2","key":"10.1002\/14651858.CD007324.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3928\/23258160-20130130-02","article-title":"Intravitreal implant migration into anterior chamber in a post-vitrectomy eye with central retinal vein occlusion and persistent macular edema","volume":"44","author":"Turaka","year":"2013","journal-title":"Ophthalmic Surgery, Lasers and Imaging Retina"},{"issue":"5","key":"10.1002\/14651858.CD007324.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ajo.2005.01.001","article-title":"Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion","volume":"139","author":"Williamson","year":"2005","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD007324.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000088388","article-title":"Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection","volume":"219","author":"Yang","year":"2005","journal-title":"Ophthalmologica"},{"issue":"3","key":"10.1002\/14651858.CD007324.pub3-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007324","article-title":"Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion","author":"Gewaily","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007324.pub3-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007324.pub2","article-title":"Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion","author":"Gewaily","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007324.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T22:03:39Z","timestamp":1666908219000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007324.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,9]]},"references-count":86,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007324.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,9]]}}}